The Ulcerative Colitis market continues to advance as new therapies and diagnostics redefine patient management and commercial potential. Driven by increasing disease prevalence and evolving treatment protocols, this market is pivotal in shaping gastroenterology care paradigms globally. Understanding the market size and growth opportunities remains crucial for stakeholders aiming to capitalize...